NCT06372626 2024-06-14
Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2 Recruiting
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
National Cancer Institute (NCI)